{
  "abstract": "Background: Perioperative clopidogrel management in total knee arthroplasty (TKA) is challenging because interruption may increase thrombotic risk, whereas continuation may increase bleeding. Evidence remains limited. Methods: We retrospectively reviewed 31 consecutive patients (35 knees) undergoing primary TKA while continuing clopidogrel 75 mg daily (April 2018–September 2019). A multidisciplinary team involving orthopaedic surgery, cardiology, and anesthesiology determined continuation. One senior surgeon performed all procedures using a tourniquet-free technique with intravenous and intra-articular tranexamic acid. All patients also received low-dose aspirin for at least 2 weeks postoperatively as venous thromboembolism prophylaxis. Outcomes through 90 days included bleeding, transfusion, wound complications, infection, major adverse cardiac and cerebrovascular events, symptomatic venous thromboembolism, and anesthesia-related complications. Results: Mean age was 69 ± 6.4 years; mean estimated blood loss was 285 ± 95 mL, and mean hemoglobin decrease was 1.8 ± 0.6 g/dL. No transfusions or major bleeding occurred. Minor wound drainage followed 3 procedures (8.6%), and superficial cellulitis occurred in 1 knee (2.9%); no deep infections occurred. Four patients (12.9%) reported mild, nonspecific headaches; none met criteria for post-dural puncture headache. No clinical signs or symptoms suggestive of spinal hematoma or persistent neurologic deficit, and no myocardial infarction, stroke, or cardiovascular death, were observed. Conclusions: Clopidogrel continuation during primary TKA may be feasible in carefully selected patients receiving multidisciplinary assessment and multimodal blood management. The small sample, retrospective design, and absence of a control group preclude conclusions about comparative safety.",
  "abstract_shown": true,
  "affiliations": [
    "Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran",
    "Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Orthopedic Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran",
    "Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Orthopedic Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran; Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran",
    "Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Orthopedic Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran; Corresponding author. Joint Reconstruction Research Center, Imam Khomeini Hospital Complex, Keshavarz Boulevard, Tehran 1419733141, Iran. Tel.: +9821-6658-1586."
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Ahmad Abbaszadeh, MD"
    },
    {
      "affs": [
        1
      ],
      "name": "Seyed Mohammad Javad Mortazavi, MD"
    },
    {
      "affs": [
        2
      ],
      "name": "Mahdi Sahebi, MD, MPH"
    },
    {
      "affs": [
        3
      ],
      "name": "Mohammad Ayati Firoozabadi, MD"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/51r80msm0e9yh.bib",
  "cited_by": 0,
  "doi": "10.1016/j.artd.2026.102204",
  "fulltext_url": "http://www.sciencedirect.com/science/article/pii/S2352344126002530",
  "id": "51r80msm0e9yh",
  "issns": [
    "2352-3441"
  ],
  "landing_url": "https://doi.org/10.1016/j.artd.2026.102204",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RD701-811"
    ],
    [
      "openalex",
      "2705|Antiplatelet Therapy and Cardiovascular Diseases"
    ]
  ],
  "openalex": "W7225613892",
  "pdf_url": "https://www.arthroplastytoday.org/article/S2352-3441(26)00253-0/pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-11",
  "publisher": "Elsevier",
  "ris": "https://research.draconitic.com/paper/51r80msm0e9yh.ris",
  "sources": [
    {
      "first_seen": "2026-11-11T14:21:27Z",
      "native_id": "0804bcb584ea40a3bc0bfc47685fbaed",
      "source": "doaj",
      "url": "https://doi.org/10.1016/j.artd.2026.102204"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2705|Antiplatelet Therapy and Cardiovascular Diseases",
      "subfield": "cardiovascular"
    }
  ],
  "title": "Continuation of Clopidogrel in Total Knee Arthroplasty: Perioperative Bleeding and Cardiovascular Outcomes in a Consecutive Case Series",
  "title_text": "Continuation of Clopidogrel in Total Knee Arthroplasty: Perioperative Bleeding and Cardiovascular Outcomes in a Consecutive Case Series",
  "type": "peer-reviewed",
  "updated_at": "2026-11-13T15:20:25Z",
  "url": "https://research.draconitic.com/paper/51r80msm0e9yh",
  "venue": "Arthroplasty Today",
  "versions": []
}